CD44-positive (CD44+) ovarian tumor cell subpopulations have been shown to express stem cell markers and are able to initiate tumorigenesis and promote disease recurrence by recapitulating the original tumor (52, 53). This evidence concerns the gene CD44 and ovarian neoplasm.